Does Intralipid Infusion Can Reverse the Spinal Anesthesia Effect in Day Case Surgery?
Launched by BENHA UNIVERSITY · Jun 10, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving a medicine called intralipid can help reverse the effects of spinal anesthesia used during short, same-day surgeries. Spinal anesthesia is a type of pain relief injected near the spine to numb the lower part of the body during surgery. The researchers want to see if intralipid infusion can speed up recovery from this numbness, helping patients feel normal sooner after their procedure.
The study is looking for adults aged 18 to 65 who are healthy enough for outpatient surgery and scheduled for a planned surgery lasting less than 90 minutes under spinal anesthesia. Both men and women can join, but people with allergies to local anesthetics, those on blood thinners, pregnant women, emergency cases, or those not suitable for outpatient surgery won’t be eligible. Participants can expect to receive spinal anesthesia as usual and then be given intralipid to see if it helps reverse the numbness faster. This study is not yet recruiting, but it aims to improve recovery times for patients having quick surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 18 to 65 years.
- • Both sexes.
- • American Society of Anesthesiology (ASA) physical status I-II.
- • Scheduled for day-case surgery under spinal anesthesia.
- • Time of surgery less than 90 min.
- Exclusion Criteria:
- • Patients with contraindications for outpatient surgery or spinal anesthesia.
- • Local anaesthetic (LA) allergy.
- • Those receiving anticoagulant therapy.
- • Emergency cases.
- • Pregnant cases.
About Benha University
Benha University, a leading institution in Egypt, is dedicated to advancing medical research and innovation through rigorous clinical trials. With a strong emphasis on multidisciplinary collaboration, the university aims to enhance healthcare outcomes by exploring novel therapeutic approaches and interventions. Its state-of-the-art facilities and commitment to ethical research practices ensure that all trials are conducted with the highest standards of integrity and scientific rigor. Benha University actively contributes to the global medical community by fostering partnerships and disseminating findings that can improve patient care and inform public health policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Banhā, Banha, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported